World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
96
Citations
33358
World Ranking
857
National Ranking
29

Philip M. Hansbro publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Philip M. Hansbro sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 680 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Philip M. Hansbro D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Philip M. Hansbro sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 96 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Philip M. Hansbro is affiliated with the University of Technology Sydney in Australia. Their research spans multiple disciplines primarily within Medicine and Biochemistry, Genetics and Molecular Biology, with a specific focus on pulmonary and respiratory medicine, molecular biology, and immunology.

The scientist's recent publications cover a range of topics related to respiratory diseases and molecular mechanisms. Notable papers include:

  • Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease, 2020, Nature Communications
  • Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update, 2020, Inflammopharmacology
  • Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages, 2022, Cell Metabolism
  • Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives, 2022, Biomedicine & Pharmacotherapy
  • Therapeutic targets in lung tissue remodelling and fibrosis, 2021, Pharmacology & Therapeutics

Philip M. Hansbro's frequent coauthors include:

  • Keshav Raj Paudel
  • Kamal Dua
  • Dinesh Kumar Chellappan
  • Sachin Kumar Singh
  • Brian G. Oliver

The scientist commonly publishes in several key venues related to respiratory and biomedical research. These include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • Nanomedicine
  • Chemico-Biological Interactions
  • Future Medicinal Chemistry

Main fields of study encompass Medicine with 428 publications and Biochemistry, Genetics and Molecular Biology with 187 publications. Subfields of specialization include Pulmonary and Respiratory Medicine, Molecular Biology, Immunology, Physiology, and Infectious Diseases.

The primary research topics include:

  • Asthma and respiratory diseases
  • Neonatal Respiratory Health Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Pediatric health and respiratory diseases
  • IL-33, ST2, and ILC Pathways
  • Inhalation and Respiratory Drug Delivery
  • Gut microbiota and health

Best Publications

  • Emerging pathogenic links between microbiota and the gut-lung axis

    Kurtis F. Budden;Shaan L. Gellatly;David L. A. Wood;Matthew A. Cooper

  • The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation

    Bernardo S Franklin;Lukas Bossaller;Dominic De Nardo;Jacqueline M Ratter

  • Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

    Gerard E. Kaiko;Jay C. Horvat;Kenneth W. Beagley;Philip M. Hansbro

  • Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.

    Meenu Mehta;Deeksha;Devesh Tewari;Gaurav Gupta

  • Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals

    Kate L. Ormerod;David L. A. Wood;Nancy Lachner;Shaan L. Gellatly

  • Role for NLRP3 Inflammasome-mediated, IL-1β-Dependent Responses in Severe, Steroid-Resistant Asthma.

    Richard Y Kim;James W Pinkerton;Ama T Essilfie;Avril A B Robertson

  • The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

    Kamal Dua;Kamal Dua;Kamal Dua;Ridhima Wadhwa;Gautam Singhvi;Vamshikrishna Rapalli

  • Functional effects of the microbiota in chronic respiratory disease.

    Kurtis F Budden;Shakti D Shukla;Saima Firdous Rehman;Kate L Bowerman

  • Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

    Simon Keely;Nicholas J. Talley;Philip M. Hansbro

  • Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease.

    Kate L. Bowerman;Saima Firdous Rehman;Annalicia Vaughan;Nancy Lachner

  • Microbiome effects on immunity, health and disease in the lung.

    Shakti D Shukla;Kurtis F Budden;Rachael Neal;Philip M Hansbro

  • Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update.

    Meenu Mehta;Daljeet S. Dhanjal;Keshav R. Paudel;Bhupender Singh

  • Interferon-ε protects the female reproductive tract from viral and bacterial infection.

    Ka Yee Fung;Niamh E. Mangan;Helen Cumming;Jay C. Horvat

  • A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis

    Emma L. Beckett;Richard L. Stevens;Richard L. Stevens;Andrew G. Jarnicki;Richard Y. Kim

  • Airway epithelial regulation of pulmonary immune homeostasis and inflammation.

    Teal S. Hallstrand;Tillie L. Hackett;William A. Altemeier;Gustavo Matute-Bello

  • MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2

    Richard Y. Kim;Jay C. Horvat;James W. Pinkerton;Malcolm R. Starkey

  • Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection

    Linda J. Berry;Danica K. Hickey;Kathryn A. Skelding;Shisan Bao

  • Animal models of chronic obstructive pulmonary disease

    Michael Fricker;Andrew Deane;Philip M Hansbro

  • Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery

    Daniel J. McIlroy;Andrew G. Jarnicki;Gough G. Au;Natalie Lott

  • Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease.

    Ama-Tawiah Essilfie;Jodie L. Simpson;Jodie L. Simpson;Jay C. Horvat;Julie A. Preston

  • The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD

    Janice M. Leung;Pei Yee Tiew;Micheál Mac Aogáin;Kurtis F. Budden

  • Cytokine/anti-cytokine therapy - novel treatments for asthma?

    Philip M Hansbro;Gerard E Kaiko;Paul S Foster

  • Nanoparticles in Cancer Treatment: Opportunities and Obstacles.

    Rajendra Awasthi;Ariane Roseblade;Philip Michael Hansbro;Michael John Rathbone

  • SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.

    Jincheng Xu;Xiaoyue Xu;Xiaoyue Xu;Lina Jiang;Kamal Dua;Kamal Dua

Frequent Co-Authors

Jay C. Horvat
Jay C. Horvat University of Newcastle Australia
Paul S. Foster
Paul S. Foster Woolcock Institute of Medical Research
Peter A. B. Wark
Peter A. B. Wark University of Newcastle Australia
Peter G. Gibson
Peter G. Gibson University of Newcastle Australia
Brian G. Oliver
Brian G. Oliver Woolcock Institute of Medical Research
Kenneth W. Beagley
Kenneth W. Beagley Queensland University of Technology
Darryl A. Knight
Darryl A. Knight University of Newcastle Australia
Joerg Mattes
Joerg Mattes University of Newcastle Australia
Ian M. Adcock
Ian M. Adcock Imperial College London
Lisa Wood
Lisa Wood University of Newcastle Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open diverse career opportunities. Many professionals in immunology often pursue complementary nursing degrees to enhance patient care skills and clinical knowledge.

Non-nurses can start their journey by enrolling in the online RN programs for non nurses, which offer a flexible pathway into registered nursing without prior healthcare experience. These programs are designed to build foundational nursing skills while accommodating working students.

For faster entry into nursing, students may consider the easiest accelerated nursing programs. These programs provide an expedited route to a Bachelor of Science in Nursing, ideal for those aiming to advance quickly.

Practical Nursing is another avenue, with easiest LPN programs to get into offering accessible options for obtaining Licensed Practical Nurse credentials. LPNs support immunology teams with patient care and clinical tasks.

Finally, for experienced nurses seeking advanced practice roles, easiest NP programs to get into provide streamlined pathways to Nurse Practitioner roles, combining nursing expertise with specialized medical knowledge relevant to immunology.

Best Scientists Citing Philip M. Hansbro

Trending Scientists

Recently Published Articles